Fall is upon us, and with it comes harvest season for both the hemp and cannabis industries. The hemp CBD industry has slowly become a synthetic minor cannabinoids market, whereas the cannabis industry continues to be dominated by flower. Due to this changing environment, we have determined different information that could provide your organization with significantly more benefits. Over the course of the next three months, we will revamp our trends section to fit the changing environment. For instance, when looking at the derivatives market for the hemp industry, the proliferation of THC-O and HHC has skyrocketed. This is less than a year after Delta 8 was banned in several states. The cat and mouse game between struggling hemp manufacturers and regulators shows no sign of stopping as the myriad of new minors continues to make their way into new consumer products. Prices for both HHC and THC-O increased from last month, showing signs that the demand for these CBD synthetic derivatives is starting to rise. Only time will tell how the battle between manufacturers and regulators will play out in regards to the minor cannabinoid market.
Kellen Finney, Eighth Revolution
Editors’ Note: This is an excerpt from our Monthly Playbook. If you would like to read the full monthly playbook and join the thousands of others you can sign up below.
